...Jia Wei; Jinhuan Xu; Yang Cao; Jianfeng Zhou; Yicheng Zhang Peripheral T-cell lymphoma (PTCL) comprises a heterogeneous group of mature T-cell tumors with a poor prognosis; allogeneic stem cell transplantation (allo-SCT) may offer a potential way of cure for these patients though the optimal type...

...Sang Pyo Lee; Sanghui Park; Jinny Park; Junshik Hong; Young Hyeh Ko Background: CD99 immunoreactivity has been documented in a variety of tumors, including lymphoid malignancies such as anaplastic large-cell lymphomas. However, few studies have investigated the prognostic impact of CD99 in diffuse...

... to treatment or progressive disease altered the pool size. The splenic pool could be discharged with adrenaline and noradrenaline. 4 3 2009 Erythrocyte mass Lymphomas Myeloproliferative disorders Spleen pool Splenomegaly Acta Haemat. 49: 215-222 (1973) Factors Influencing Splenic Pooling...

.... In 23 patients affected by un­ Key Words treated Hodgkin s disease, 67Ga citrate scan­ 67Ga scanning ning was performed as part of a clinical and Hodgkin staging pathological staging protocol. A good correla­ Isotope techniques in lymphomas tion (16/23) between 67Ga scans and other di­ agnostic...

...Lars-Bertil Olsson; Jack Kutti; Aleksander Weinfeld Duplicate platelet survival studies, using autologous platelets labelled in vitro with radioactive sodium chromate, were carried out on 5 lymphoma patients who had been splenectomized 14–21 months earlier. In the first experiment plasma...

...P. Klener; L. Donner 15 patients with malignant lymphomas (stage III B or IV) who had become resistant to previous combination chemotherapy were treated with DTIC. The drug was administered intravenously as a single agent in doses of 300 mg/m2 on 5 consecutive days, once a month. The results...

..., instructions or products referred to in the content or advertisements. Hodgkin’s disease Lymphomas M components Paraproteins Acta haemat. 55: 250-255 (1976) Two Serum IgG-M Components of Different Light-Chain Types in a Case of Hodgkin s Disease T. C hisesi, G. Capnist and T. Barbui Divisione di...

...%) in subsequent remission and early relapse. BMT of autologous BMT with 4-hydroperoxy-cyclophosphamide (4-HC) purged marrow in ANLL in CRl (5), CR2 (32) and CR3 (9) following Bu + Cy resulted in DFS of 19/46 (41%) for 1–67 months (median 15 months). Twenty patients with prior risk non-Hodgkin’s lymphoma received...

... cycle. The objective of this study was to investigate the role of promoter methylation of p 16 INK4A and MAD 2 genes in gastric marginal-zone B-cell lymphoma (MZBCL). Materials and Methods: Gastric biopsies from 40 patients were analyzed by methylation-specific polymerase chain reaction...

... in the prognosis and extranodal involvement of diffuse large B-cell lymphomas (DLBCL). Thus, we measured serum 90K concentration by enzyme-linked immunosorbent assay and tissue expression of galectin-3 by immunohistochemistry in newly diagnosed DLBCL patients. The mean serum 90K concentration was higher in DLBCL...